PolandOther
Ongoing supply of medicine for a treatment program – agalsidase alfa
The procurement covers ongoing supply of agalsidase alfa for a treatment program. It is intended to provide this enzyme medicine for patient treatment under the program.
- Published
- 23 Jul 2026
- CPV
- 33600000
Get help from a local consultant
Bidding cross-border? A Baltmodus consultant who works in this market can help you prepare and submit.
Find a consultant